Common Contracts
32 similar Employment Agreement contracts by Tyra Biosciences, Inc., Sienna Biopharmaceuticals, Inc., Unity Biotechnology, Inc., others
INHIBITOR THERAPEUTICS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • December 19th, 2022 • Inhibitor Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Employment Agreement (the “Agreement”), entered into as of December 13, 2022 (the “Effective Date”), is made by and between Inhibitor Therapeutics, Inc., a Delaware corporation (the “Company”) and Francis E. O’Donnell (“Executive” and, together with the Company, the “Parties”).
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 16th day of January, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Ronald Swanson (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”) is entered into this 6th day of January, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Todd Harris (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 1st day of January, 2021 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Robert Hudkins (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 18th day of January, 2021 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Piyush Patel (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 9th day of November, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Hiroomi Tada (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 16th day of April, 2021 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Esther van den Boom (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”) is entered into this 6th day of January, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Dan Bensen (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 9th day of November, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Hiroomi Tada (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 18th day of January, 2021 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Piyush Patel (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”) is entered into this 6th day of January, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Dan Bensen (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 16th day of January, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Ronald Swanson (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Amended and Restated Employment Agreement (the “Agreement”) is entered into this 6th day of January, 2020 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Todd Harris (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 1st day of January, 2021 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Robert Hudkins (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
TYRA BIOSCIENCES, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2021 • Tyra Biosciences, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is entered into this 16th day of April, 2021 (the “Effective Date”), by and between Tyra Biosciences, Inc., a Delaware corporation (the “Company”) and Esther van den Boom (“Executive” and, together with the Company, the “Parties”). Capitalized terms used herein and not otherwise defined shall have those meanings set forth in Appendix I hereto.
EX-10.7 15 d391086dex107.htm EX-10.7 SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Frederick Beddingfield, III, M.D., Ph.D. (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and Sienna Labs, Inc. dated as of January 6, 2016 (the “Prior Agreement”).
EX-10.12 25 d535851dex1012.htm EX-10.12 UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Dan Marquess (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of October 28, 2015(“Offer Letter”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 8th, 2019 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Alexander Azoy (“Executive” and, together with the Company, the “Parties”), effective as of April 1, 2019 (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of November 7, 2017 (the “Prior Agreement”).
GRITSTONE ONCOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 17th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”), entered into as of September 16, 2018 (the “Agreement Date”), is between Gritstone Oncology, Inc., a Delaware corporation (the “Company”) and Jayant Aphale (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as a binding contract as of the Agreement Date, but the operative provisions of this Agreement will only become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of February 9, 2018 (“Offer Letter”).
GRITSTONE ONCOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • September 17th, 2018 • Gritstone Oncology, Inc. • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”), entered into as of September 16, 2018 (the “Agreement Date”), is between Gritstone Oncology, Inc., a Delaware corporation (the “Company”) and Karin Jooss (“Executive” and, together with the Company, the “Parties”). This Agreement will become effective as a binding contract as of the Agreement Date, but the operative provisions of this Agreement will only become effective as of immediately prior to the time the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter between Executive and the Company dated as of February 29, 2016 (“Offer Letter”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • May 14th, 2018 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and John Smither (“Executive” and, together with the Company, the “Parties”), effective as of April 16, 2018 (the “Effective Date”).
UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Tamara Tompkins (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of May 31, 2017 (“Offer Letter”).
UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Bob Goeltz (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of August 8, 2017 (“Offer Letter”).
UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Nathaniel David (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of April 20, 2009 (“Offer Letter”).
UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Jamie Dananberg (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of December 22, 2015 (“Offer Letter”).
UNITY BIOTECHNOLOGY, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 23rd, 2018 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), entered into as of January 29, 2018 (the “Effective Date”), is made by and between Unity Biotechnology, Inc., a Delaware corporation (the “Company”) and Dan Marquess (“Executive” and, together with the Company, the “Parties”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of October 28, 2015(“Offer Letter”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 3rd, 2017 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Paul F. Lizzul (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and Sienna Labs, Inc. dated as of January 9, 2016 (the “Prior Agreement”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 3rd, 2017 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Diane Stroehmann (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and Sienna Labs, Inc. dated as of January 7, 2016 (the “Prior Agreement”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 3rd, 2017 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Richard D. Peterson (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of March 22, 2017 (the “Prior Agreement”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 3rd, 2017 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Todd Harris (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and Sienna Labs, Inc. dated as of September 1, 2014 (the “Prior Agreement”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 3rd, 2017 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Frederick Beddingfield, III, M.D., Ph.D. (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain Employment Agreement by and between Executive and Sienna Labs, Inc. dated as of January 6, 2016 (the “Prior Agreement”).
SIENNA BIOPHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • July 3rd, 2017 • Sienna Biopharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”), is made by and between Sienna Biopharmaceuticals, Inc., a Delaware corporation (the “Company”) and Timothy Andrews (“Executive” and, together with the Company, the “Parties”), effective as of the date the Company’s registration statement relating to the initial public offering of the Company’s common stock becomes effective (the “Effective Date”). This Agreement supersedes in its entirety that certain offer letter by and between Executive and the Company dated as of October 3, 2016 (the “Prior Agreement”).
